NCT05392127View on ClinicalTrials.gov

A Pharmacokinetic Study to Evaluate the Drug Interaction Between SHR0302 and CYP Substrates in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

July 15, 2022

Primary Completion Date

August 18, 2022

Study Completion Date

August 18, 2022

Conditions
Rheumatoid Arthritis
Interventions
DRUG

SHR0302 Tablets

SHR0302 Tablets once daily

DRUG

Midazolam Maleate Tablets

Midazolam Maleate Tablets single dose

DRUG

Warfarin Sodium Tablets

Warfarin Sodium Tablets single dose

DRUG

Omeprazole Enteric Capsules

Omeprazole Enteric Capsules single dose

DRUG

Vitamin K1 Tablets

Vitamin K1 Tablets once daily

DRUG

Repaglinide Tablets

Repaglinide Tablets single dose

Trial Locations (1)

430000

Zhongnan Hospital of Wuhan University, Wuhan

All Listed Sponsors
lead

Jiangsu HengRui Medicine Co., Ltd.

INDUSTRY